Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is kaposi sarcoma?
Kaposi sarcoma is an unusual cancer that develops from the cells lining blood and lymph vessels. It is caused by a virus — human herpesvirus 8 (HHV-8), also called Kaposi sarcoma-associated herpesvirus — which most people's immune systems keep in check. Kaposi sarcoma typically appears when the immune system is weakened, so it tends to occur in people living with HIV/AIDS, in those taking medicines that suppress the immune system after an organ transplant, and, in certain populations and older adults, in a slower-growing form. The cancer most often shows up on the skin as purple, red, or brown patches, plaques, or nodules, commonly on the legs, feet, or face, and inside the mouth. It can also involve lymph nodes and internal organs such as the lungs and digestive tract, where it can cause more serious problems like bleeding or breathing difficulty. A defining feature of Kaposi sarcoma is how closely it is tied to the immune system: in many cases, restoring immune function — by treating HIV effectively or adjusting transplant medicines — causes the lesions to shrink or disappear, which is why managing the underlying cause is the foundation of treatment. When lesions need direct treatment, Kaposi sarcoma is notably sensitive to radiation, and other options include local therapies and, for widespread disease, chemotherapy.
The main types
Doctors group kaposi sarcoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Epidemic (HIV-associated) Kaposi sarcoma | Occurs in people with HIV; the cornerstone of treatment is effective HIV therapy to restore the immune system, which alone often causes lesions to regress. |
| Iatrogenic (transplant-related) Kaposi sarcoma | Occurs in people taking immune-suppressing medicines after an organ transplant; reducing or changing those medicines, when safe, often improves the disease. |
| Classic Kaposi sarcoma | A slow-growing form seen mainly in older adults of Mediterranean or Eastern European descent, usually limited to the skin of the legs and often managed with local treatments such as radiation. |
| Endemic (African) Kaposi sarcoma | A form found in parts of Africa that can range from indolent skin disease to a more aggressive course, sometimes affecting lymph nodes and organs, especially in children. |
Staging, in plain terms
Kaposi sarcoma is not staged with the usual TNM number system used for many solid tumors. Because it is so closely linked to the immune system and can range from a few skin spots to widespread internal disease, doctors describe it by how extensive and aggressive it is. For Kaposi sarcoma associated with HIV, a widely used framework called the ACTG system looks at three things: the extent of the Tumor (limited to skin versus involving the mouth, lymph nodes, or internal organs), the strength of the Immune system (measured by the CD4 cell count), and whether there is Systemic illness (such as other infections or general decline). These three factors together — rather than a single number — sort patients into better- or poorer-risk groups and help guide how aggressive treatment should be. For other forms, doctors simply judge whether the disease is confined to the skin or has spread to organs, how fast it is progressing, and how much it is affecting the patient. In every form, a central question is the state of the immune system, because improving it is often the most powerful treatment.
| Extent and aggressiveness rather than TNM — for HIV-associated disease, the ACTG system using Tumor extent, Immune status, and Systemic illness | What it generally means |
|---|---|
| Limited skin disease, good immune status | A small number of skin lesions with a relatively healthy immune system; often controlled by treating the underlying cause and with local treatments such as radiation to individual lesions. |
| Extensive skin or mucous-membrane disease | More numerous or widespread lesions on the skin or in the mouth; treated with immune restoration plus local therapy or, if widespread, systemic chemotherapy. |
| Organ involvement (lungs, digestive tract, lymph nodes) | Disease affecting internal organs, which can cause bleeding or breathing problems; treated more aggressively, usually with chemotherapy alongside immune restoration. |
| Poor immune status or systemic illness | Disease in the setting of a very weak immune system or other serious illness; restoring immune function is critical, combined with systemic treatment for the cancer. |
The standard of care
Kaposi Sarcoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Restoring the immune system
The foundation of treatment: effective HIV therapy for HIV-associated disease, or reducing/adjusting immune-suppressing medicines after a transplant when safe. This alone often causes lesions to shrink or disappear.
Radiation therapy
Kaposi sarcoma is very sensitive to radiation, which is highly effective for treating individual or grouped skin lesions, painful or bleeding spots, and lesions in cosmetically or functionally important areas.
Local therapies
For limited skin disease, options include freezing lesions, injecting medicine directly into them, applying topical treatments, or minor procedures to remove them.
Systemic chemotherapy
For widespread skin disease or involvement of internal organs, chemotherapy (such as liposomal anthracyclines or taxanes) treats the disease throughout the body.
Supportive care and clinical trials
Managing symptoms, controlling bleeding, and access to newer immune-based and targeted treatments through trials round out care, especially for difficult disease.
How radiation treatment works
Radiation therapy uses focused high-energy beams to damage the DNA inside tumor cells so they can no longer grow and divide. Kaposi sarcoma is one of the more radiosensitive cancers, meaning its lesions respond readily to relatively modest doses of radiation — which makes radiation a valuable and reliable tool for treating individual or grouped lesions. It is especially useful for spots that are painful, bleeding, cosmetically distressing, or interfering with function, such as lesions on the feet that make walking difficult or in the mouth that cause discomfort. Because most Kaposi sarcoma lesions sit in or just under the skin, doctors often use electron beams, which deliver their dose to the skin's depth and then stop, treating the lesion while protecting the deeper, healthy tissue beneath. A focused course typically causes lesions to flatten, fade in color, and stop causing symptoms. It is important to understand that radiation treats the lesions it is aimed at but does not address the underlying cause — the virus held in check by the immune system — which is why radiation is almost always combined with the most important step of all: restoring immune function by treating HIV effectively or adjusting transplant medicines. For widespread disease or internal-organ involvement, chemotherapy works throughout the body, while radiation remains the go-to for controlling specific problem lesions. As with all radiation, treatment is planned to relieve symptoms and control disease while sparing healthy skin and tissue.
The main ways radiation is delivered for kaposi sarcoma:
Localized external-beam radiation to skin lesions
Because Kaposi sarcoma is highly radiosensitive, a focused, often short course of radiation to a lesion or group of lesions reliably causes them to flatten, fade, and stop causing symptoms, while sparing surrounding skin.
Superficial electron-beam radiation
Electron beams deposit their energy in the skin and stop, making them well suited to treating skin lesions while protecting the deeper tissue beneath.
Palliative radiation
Radiation quickly relieves pain, bleeding, or swelling from troublesome lesions — for example in the mouth, on the feet, or where lesions interfere with daily function.
Radiation for lymph node or localized internal disease
Focused radiation can be directed at enlarged, symptomatic lymph nodes or a localized internal site to control disease and relieve symptoms, complementing systemic treatment.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Effective HIV therapy drives Kaposi sarcoma regression: Studies confirm that modern antiretroviral therapy, by restoring the immune system, causes many HIV-associated Kaposi sarcoma lesions to shrink or disappear and dramatically reduces new cases, making it the foundation of treatment.[1]
HIV-associated Kaposi sarcoma studies
Radiation reliably controls localized lesions: Series of patients treated with focused radiation report high rates of lesion response and durable symptom relief, reinforcing radiation's role for painful, bleeding, or cosmetically important Kaposi sarcoma spots.[2]
Kaposi sarcoma radiotherapy reports
Liposomal chemotherapy and emerging immune therapies: Liposomal anthracyclines remain a mainstay for advanced disease, while newer immune-based and antiangiogenic treatments are being studied for Kaposi sarcoma that does not respond to standard approaches.[3]
Advanced Kaposi sarcoma treatment trials
Common questions
Why does treating my immune system help the cancer? Kaposi sarcoma is caused by a virus that a healthy immune system normally keeps under control. When the immune system is weakened — by HIV or by transplant medicines — the virus can drive tumor growth. Restoring immune function with effective HIV therapy, or adjusting transplant medicines when safe, often causes the lesions to shrink or disappear, which is why it is the cornerstone of treatment.
How well does radiation work for Kaposi sarcoma? Very well for the lesions it targets. Kaposi sarcoma is highly sensitive to radiation, so a focused, often short course reliably flattens and fades lesions and relieves pain or bleeding, while sparing the surrounding skin. It is a go-to option for individual problem spots, used alongside treating the underlying immune cause.
Is Kaposi sarcoma contagious? The cancer itself is not contagious. The virus that causes it can be passed between people, but most people who carry the virus never develop Kaposi sarcoma because a healthy immune system keeps it in check. The disease typically appears only when the immune system is significantly weakened.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.